[go: up one dir, main page]

GB811411A - Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom - Google Patents

Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom

Info

Publication number
GB811411A
GB811411A GB13638/57A GB1363857A GB811411A GB 811411 A GB811411 A GB 811411A GB 13638/57 A GB13638/57 A GB 13638/57A GB 1363857 A GB1363857 A GB 1363857A GB 811411 A GB811411 A GB 811411A
Authority
GB
United Kingdom
Prior art keywords
cells
tissue culture
culture fluid
embryonic
infectious hepatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB13638/57A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of GB811411A publication Critical patent/GB811411A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/706Specific hybridization probes for hepatitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32411Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GB13638/57A 1956-04-30 1957-04-29 Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom Expired GB811411A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US811411XA 1956-04-30 1956-04-30

Publications (1)

Publication Number Publication Date
GB811411A true GB811411A (en) 1959-04-02

Family

ID=22162337

Family Applications (1)

Application Number Title Priority Date Filing Date
GB13638/57A Expired GB811411A (en) 1956-04-30 1957-04-29 Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom

Country Status (2)

Country Link
GB (1) GB811411A (es)
NL (1) NL97686C (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313706A (en) * 1965-06-08 1967-04-11 Johnson & Johnson Diagnostic antigen for viral hepatitis
EP0025745A1 (en) * 1979-09-04 1981-03-25 Merck & Co. Inc. Process for propagating human hepatitis A virus in in vitro cell culture
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313706A (en) * 1965-06-08 1967-04-11 Johnson & Johnson Diagnostic antigen for viral hepatitis
EP0025745A1 (en) * 1979-09-04 1981-03-25 Merck & Co. Inc. Process for propagating human hepatitis A virus in in vitro cell culture
US5514376A (en) * 1979-09-04 1996-05-07 Merck & Co., Inc. Cell culture of hepatitis A virus
US5766603A (en) * 1979-09-04 1998-06-16 Merck & Co., Inc. Cell culture of hepatitis A virus

Also Published As

Publication number Publication date
NL97686C (es)

Similar Documents

Publication Publication Date Title
KR900001382A (ko) 연속 셀라인에서의 ibdv생성
ATE2014T1 (de) Lebendes, attenuiertes virus des hepatitis a beim menschen, verfahren zu seiner zuechtung in zellkultur in vitro und dieses virus enthaltende zusammensetzung.
ATE7855T1 (de) Herstellung von virusantigenen.
ES8104405A1 (es) Procedimiento para preparar una vacuna de virus de gripe
GB811411A (en) Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom
ES486442A0 (es) Un metodo de preparar una vacuna que contiene una cepa ate- nuada de virus de peritonitis infecciosa felina.
GB894603A (en) Improvements in or relating to vaccines
GB1488800A (en) Influenza vaccines
US3255081A (en) Anti-viral vaccines immunized against oncogenic viruses
GB806949A (en) Production of pharmaceutical preparations
GB1039722A (en) Process for the manufacture of a foot-and-mouth disease vaccine containing a live virus
GB1016586A (en) Vaccine for immunization of dogs against distemper and hepatitis contagiosa canis
ES8107024A1 (es) Metodo para preparar una vacuna que contiene virus desacti- vado de peritonilis infecciosa felina.
ES8200398A1 (es) Un procedimiento para el cultivo celular in vitro del virus de la hepatitis b.
Bawden et al. The Production of Antisera with Suspensions of Potato Virus “X” Inactivated by Nitrous Acid
ES390873A1 (es) Un procedimiento de cultivo de virus.
ES317455A1 (es) Procedimiento para la produccion de una vacuna antigena somatica.
GB1039614A (en) Process for the manufacture of a foot-and-mouth disease vaccine containing a live virus
FR2290220A2 (fr) Nouveau vaccin antirabique
GB1267591A (en) Antigenic materials
FR1600962A (en) New prepn of measles virus suspensions
Kääriäinen et al. Metabolic inhibition test for louping-ill, measles and herpes simplex virus in plastic panels
ES226832A1 (es) Un procedimiento para producir un producto de vacuna contra la poliomelitis
GB984444A (en) Process for the manufacture of a vaccine containing a live foot-and-mouth disease virus
FR2150799A1 (en) Equine infectious anaemia - prepn of immunising vaccine